Effect of risperidone on emotion recognition deficits in antipsychotic-naïve schizophrenia: A short-term follow-up study

Schizophrenia Research

Volumn 113, Issue 1, 2009, Pages 72-76

  Behere, Rishikesh V ^a   Venkatasubramanian, Ganesan ^a   Arasappa, Rashmi ^a   Reddy, Nalini ^a   Gangadhar, Bangalore N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Antipsychotic na ve; Disgust; Emotion recognition; Schizophrenia

Indexed keywords

RISPERIDONE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; EMOTIONALITY; FEAR; FOLLOW UP; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT COURSE THERAPY;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; COGNITIVE THERAPY; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649853086     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.05.026     Document Type: Article

References (33)

1. Andreasen N.C., and Olsen S. Negative v positive schizophrenia. Definition and validation. Arch. Gen. Psychiatry 39 (1982) 789-794
2. Bediou B., Krolak-Salmon P., Saoud M., Henaff M., Burt M., Dalery J., and D'Amato T. Facial expression and sex recognition in schizophrenia and depression. Can. J. Psychiatry 50 (2005) 525-533
3. Bediou B., Asri F., Brunelin J., Krolak-Salmon P., D'Amato T., Saoud M., and Tazi I. Emotion recognition and genetic vulnerability to schizophrenia. Br. J. Psychiatry 191 (2007) 126-130
4. Behere R.V., Raghunandan V.N., Venkatasubramanian G., Subbakrishna D.K., Jayakumar P.N., and Gangadhar B.N. TRENDS: a Tool for Recognition of Emotions in Neuropsychiatric DisorderS. (Winner of Dr DS Raju memorial award for best Postgraduate paper presentation at the annual conference of Indian Psychiatric Society, South-Zone, 2007). Indian J. Psychol. Med. 30 (2008) 32-38
5. Elfenbein H.A., Mandal M.K., Ambady N., Harizuka S., and Kumar S. Cross-cultural patterns in emotion recognition: highlighting design and analytical techniques. Emotion 2 (2002) 75-84
6. Furey M.L., Pietrini P., Haxby J.V., and Drevets W.C. Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 33 (2008) 913-923
7. Grady C.L., and Keightley M.L. Studies of altered social cognition in neuropsychiatric disorders using functional neuroimaging. Can. J. Psychiatry 47 (2002) 327-336
8. Green M.J., and Phillips M.L. Social threat perception and the evolution of paranoia. Neurosci. Biobehav. Rev. 28 (2004) 333-342
9. Harvey P.D., Patterson T.L., Potter L.S., Zhong K., and Brecher M. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am. J. Psychiatry 163 (2006) 1918-1925
10. Hennenlotter A., Schroeder U., Erhard P., Haslinger B., Stahl R., Weindl A., von Einsiedel H.G., Lange K.W., and Ceballos-Baumann A.O. Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 127 (2004) 1446-1453
11. Herbener E.S., Hill S.K., Marvin R.W., and Sweeney J.A. Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia. Am. J. Psychiatry 162 (2005) 1746-1748
12. Hori H., Noguchi H., Hashimoto R., Nakabayashi T., Omori M., Takahashi S., Tsukue R., Anami K., Hirabayashi N., Harada S., Saitoh O., Iwase M., Kajimoto O., Takeda M., Okabe S., and Kunugi H. Antipsychotic medication and cognitive function in schizophrenia. Schizophr. Res. 86 (2006) 138-146
13. Johnston P.J., Enticott P.G., Mayes A.K., Hoy K.E., Herring S.E., and Fitzgerald P.B. Symptom correlates of static and dynamic facial affect processing in schizophrenia: evidence of a double dissociation?. Schizophr. Bull. (2008) (Electronic publication ahead of print)
14. Kee K.S., Kern R.S., Marshall Jr. B.D., and Green M.F. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophr. Res. 31 (1998) 159-165
15. Kee K.S., Green M.F., Mintz J., and Brekke J.S. Is emotion processing a predictor of functional outcome in schizophrenia?. Schizophr. Bull. 29 (2003) 487-497
16. Kee K.S., Horan W.P., Mintz J., and Green M.F. Do the siblings of schizophrenia patients demonstrate affect perception deficits?. Schizophr. Res. 61 (2004) 87-94
17. Klingberg S., Wittorf A., and Wiedemann G. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006) 532-540
18. Kohler C.G., Turner T.H., Bilker W.B., Brensinger C.M., Siegel S.J., Kanes S.J., Gur R.E., and Gur R.C. Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am. J. Psychiatry 160 (2003) 1768-1774
19. Kucharska-Pietura K., David A.S., Masiak M., and Phillips M.L. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br. J. Psychiatry 187 (2005) 523-528
20. Mandal M.K., Pandey R., and Prasad A.B. Facial expressions of emotions and schizophrenia: a review. Schizophr. Bull. 24 (1998) 399-412
21. Mandal M.K., Jain A., Haque-Nizamie S., Weiss U., and Schneider F. Generality and specificity of emotion-recognition deficit in schizophrenic patients with positive and negative symptoms. Psychiatry Res. 87 (1999) 39-46
22. Martin F., Baudouin J.Y., Tiberghien G., and Franck N. Processing emotional expression and facial identity in schizophrenia. Psychiatry Res. 134 (2005) 43-53
23. Murphy F.C., Nimmo-Smith I., and Lawrence A.D. Functional neuroanatomy of emotions: a meta-analysis. Cogn. Affect. Behav. Neurosci. 3 (2003) 207-233
24. Penn D.L., Sanna L.J., and Roberts D.L. Social cognition in schizophrenia: an overview. Schizophr. Bull. 34 (2008) 408-411
25. Phan K.L., Wager T., Taylor S.F., and Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16 (2002) 331-348
26. Phillips M.L., Young A.W., Senior C., Brammer M., Andrew C., Calder A.J., Bullmore E.T., Perrett D.I., Rowland D., Williams S.C., Gray J.A., and David A.S. A specific neural substrate for perceiving facial expressions of disgust. Nature 389 (1997)
27. Pinkham A.E., Gur R.E., and Gur R.C. Affect recognition deficits in schizophrenia: neural substrates and psychopharmacological implications. Expert Rev. Neurother. 7 (2007) 807-816
28. Salgado-Pineda P., Delaveau P., Blin O., and Nieoullon A. Dopaminergic contribution to the regulation of emotional perception. Clin. Neuropharmacol. 28 (2005) 228-237
29. Sergi M.J., Rassovsky Y., Widmark C., Reist C., Erhart S., Braff D.L., Marder S.R., and Green M.F. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms. Schizophr. Res. 90 (2007) 316-324
30. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 Suppl 20 (1998) 22-33 quiz 34-57
31. Spinks R., Nopoulos P., Ward J., Fuller R., Magnotta V.A., and Andreasen N.C. Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia. Schizophr. Res. 73 (2005) 229-233
32. Strauss M.E., Reynolds K.S., Jayaram G., and Tune L.E. Effects of anticholinergic medication on memory in schizophrenia. Schizophr. Res. 3 (1990) 127-129
33. Tessitore A., Hariri A.R., Fera F., Smith W.G., Chase T.N., Hyde T.M., Weinberger D.R., and Mattay V.S. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J. Neurosci. 22 (2002) 9099-9103